Clinical Trial Detail

NCT ID NCT02286726
Title CPX-351 in Treating Patients With Newly Diagnosed, High-Risk Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

Therapies

CPX-351

Age Groups: adult senior

No variant requirements are available.